FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053890147> ?p ?o ?g. }

• W2053890147 endingPage "1082" @default.
• W2053890147 startingPage "1076" @default.
• W2053890147 abstract "Background: Strict glycemic control has been shown to reduce both morbidity and mortality in critically ill surgical patients; however, overly aggressive management of hyperglycemia may also be associated with deleterious effects. We sought to characterize clinical outcomes associated with different levels of persistent hyperglycemia (PH) in a cohort of severely injured patients with trauma, when a strict glycemic control protocol (target glucose 80–110 mg/dL) was implemented. Methods: Data were obtained from a multicenter prospective cohort study evaluating clinical outcomes in blunt injured adults with hemorrhagic shock. Glycemic control was analyzed using the average maximum daily glucose values from postinjury day 2 (>48 hours after injury) to postinjury day 5. PH was defined as a mean glucose value >130 mg/dL, and was categorized into three different severity levels (I–III) based on the distribution of mean 4-day glucose values for the cohort. Separate Cox proportional hazard regression models were then used to determine whether PH was independently associated with mortality and nosocomial infection (NI), and the level of glycemic control that was associated with these poor outcomes. Results: Overall mortality and NI rates for the study population (n = 862) were 10.8% and 49.6%, respectively. Cox proportional hazard regression revealed that PH was independently associated with almost an 80% higher mortality in patients with mean 4-day glucose values >145 mg/dL (group II) and almost a twofold higher mortality in patients with >165 mg/dL (group III). However, PH was not independently associated with a higher risk of NI at any level. Patients with PH did have a higher incidence of early multiple organ failure (within first 48 hours: 30.2% vs. 41.6% p = 0.001), which preceded the documentation of PH in the majority of patients. Conclusion: Maintenance of daily maximum glucose values <145 mg/dL was independently associated with a survival benefit after injury. Patients with PH, despite aggressive insulin therapy, had a higher incidence of multiple organ failure and an associated higher risk of mortality. However, the strict glycemic control protocol in the current trauma cohort seems to have prevented the association of PH and infectious complications, which has been documented in prior studies. This analysis further validates the importance of strict glycemic control after injury, and highlights the need for further studies on the mechanism responsible for these findings." @default.
• W2053890147 created "2016-06-24" @default.
• W2053890147 creator A5012229337 @default.
• W2053890147 creator A5023300205 @default.
• W2053890147 creator A5028689777 @default.
• W2053890147 creator A5029774861 @default.
• W2053890147 creator A5041612225 @default.
• W2053890147 creator A5049570322 @default.
• W2053890147 creator A5056567031 @default.
• W2053890147 creator A5073637013 @default.
• W2053890147 date "2009-04-01" @default.
• W2053890147 modified "2023-10-06" @default.
• W2053890147 title "Characterization of Persistent Hyperglycemia: What Does It Mean Postinjury?" @default.
• W2053890147 cites W1926244529 @default.
• W2053890147 cites W1966344978 @default.
• W2053890147 cites W1972352298 @default.
• W2053890147 cites W1979061819 @default.
• W2053890147 cites W1980073234 @default.
• W2053890147 cites W1980717583 @default.
• W2053890147 cites W2001874164 @default.
• W2053890147 cites W2006153994 @default.
• W2053890147 cites W2007852978 @default.
• W2053890147 cites W2026551284 @default.
• W2053890147 cites W2033015281 @default.
• W2053890147 cites W2043553583 @default.
• W2053890147 cites W2055959024 @default.
• W2053890147 cites W2069785744 @default.
• W2053890147 cites W2085208748 @default.
• W2053890147 cites W2095009380 @default.
• W2053890147 cites W2115285670 @default.
• W2053890147 cites W2183831387 @default.
• W2053890147 cites W2419360016 @default.
• W2053890147 cites W4292543873 @default.
• W2053890147 cites W4301972348 @default.
• W2053890147 cites W49244960 @default.
• W2053890147 doi "https://doi.org/10.1097/ta.0b013e31817db0de" @default.
• W2053890147 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4004069" @default.
• W2053890147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19359917" @default.
• W2053890147 hasPublicationYear "2009" @default.
• W2053890147 type Work @default.
• W2053890147 sameAs 2053890147 @default.
• W2053890147 citedByCount "14" @default.
• W2053890147 countsByYear W20538901472012 @default.
• W2053890147 countsByYear W20538901472017 @default.
• W2053890147 countsByYear W20538901472018 @default.
• W2053890147 countsByYear W20538901472019 @default.
• W2053890147 crossrefType "journal-article" @default.
• W2053890147 hasAuthorship W2053890147A5012229337 @default.
• W2053890147 hasAuthorship W2053890147A5023300205 @default.
• W2053890147 hasAuthorship W2053890147A5028689777 @default.
• W2053890147 hasAuthorship W2053890147A5029774861 @default.
• W2053890147 hasAuthorship W2053890147A5041612225 @default.
• W2053890147 hasAuthorship W2053890147A5049570322 @default.
• W2053890147 hasAuthorship W2053890147A5056567031 @default.
• W2053890147 hasAuthorship W2053890147A5073637013 @default.
• W2053890147 hasBestOaLocation W20538901472 @default.
• W2053890147 hasConcept C126322002 @default.
• W2053890147 hasConcept C141071460 @default.
• W2053890147 hasConcept C188816634 @default.
• W2053890147 hasConcept C201903717 @default.
• W2053890147 hasConcept C207103383 @default.
• W2053890147 hasConcept C2779306644 @default.
• W2053890147 hasConcept C2780473172 @default.
• W2053890147 hasConcept C2908647359 @default.
• W2053890147 hasConcept C44249647 @default.
• W2053890147 hasConcept C50382708 @default.
• W2053890147 hasConcept C71924100 @default.
• W2053890147 hasConcept C72563966 @default.
• W2053890147 hasConcept C99454951 @default.
• W2053890147 hasConceptScore W2053890147C126322002 @default.
• W2053890147 hasConceptScore W2053890147C141071460 @default.
• W2053890147 hasConceptScore W2053890147C188816634 @default.
• W2053890147 hasConceptScore W2053890147C201903717 @default.
• W2053890147 hasConceptScore W2053890147C207103383 @default.
• W2053890147 hasConceptScore W2053890147C2779306644 @default.
• W2053890147 hasConceptScore W2053890147C2780473172 @default.
• W2053890147 hasConceptScore W2053890147C2908647359 @default.
• W2053890147 hasConceptScore W2053890147C44249647 @default.
• W2053890147 hasConceptScore W2053890147C50382708 @default.
• W2053890147 hasConceptScore W2053890147C71924100 @default.
• W2053890147 hasConceptScore W2053890147C72563966 @default.
• W2053890147 hasConceptScore W2053890147C99454951 @default.
• W2053890147 hasIssue "4" @default.
• W2053890147 hasLocation W20538901471 @default.
• W2053890147 hasLocation W20538901472 @default.
• W2053890147 hasLocation W20538901473 @default.
• W2053890147 hasLocation W20538901474 @default.
• W2053890147 hasOpenAccess W2053890147 @default.
• W2053890147 hasPrimaryLocation W20538901471 @default.
• W2053890147 hasRelatedWork W1985681015 @default.
• W2053890147 hasRelatedWork W2110531497 @default.
• W2053890147 hasRelatedWork W2803910286 @default.
• W2053890147 hasRelatedWork W2912705052 @default.
• W2053890147 hasRelatedWork W2987985474 @default.
• W2053890147 hasRelatedWork W3110151069 @default.
• W2053890147 hasRelatedWork W3164121017 @default.
• W2053890147 hasRelatedWork W4213264857 @default.
• W2053890147 hasRelatedWork W4229452352 @default.

• next